A newly uncovered immune chain reaction in the gut may explain why people with inflammatory bowel disease face a much higher ...

The preventive immunization Nous-209 works in an initial trial with patients who have 17 times the risk of developing tumors ...

Immune signaling in IBD triggers tumor-promoting neutrophils which is linked to an increased risk of colorectal cancer.

The ‘TL1A’ messenger protein of the immune system triggers gut-to-bone marrow reaction, increasing the colorectal cancer risk ...

Long-Term Alcohol Use Linked To Increased Risk Of Colon Cancer ...

A chain of immune reactions in the gut—driven by a key signaling protein and a surge of white blood cells from the bone ...

Increased stiffness of the colon, spurred by chronic inflammation, may encourage the development and progression of ...

Rates of colorectal cancer in older adults have generally improved over recent decades, but the trend is moving in the wrong direction for younger people. Early-onset colorectal cancer – cases ...

Ibuprofen may be doing more than easing aches and pains—it could also help reduce the risk of some cancers. Studies have ...

Why do some tumors spread while others remain localized? The mechanisms governing the metastatic potential of tumor cells ...

GLP-1 receptor agonists like Ozempic and Wegovy may increase survival among patients with colon cancer, reported a new study published in Cancer Investigation. GLP-1 receptor agonists were originally ...

One large study found that more advanced cases of colorectal cancer had a higher likelihood of returning. For example, if participants had stage 3 colon cancer, almost 25 percent experienced a ...